Brief Fatigue Inventory (BFI)
Also known as: BFI
The Brief Fatigue Inventory is a 9-item patient self-report instrument specifically designed for rapid, repeated assessment of cancer-related fatigue severity and its functional impact. Developed by Mendoza, Cleeland, and colleagues at M.D. Anderson Cancer Center in 1999, the BFI is optimized for use in busy oncology clinics, allowing comprehensive fatigue profiling in 2–3 minutes without sacrificing clinical validity.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
BFI is appropriate for all cancer types and stages. Use in clinical trials as a primary or secondary endpoint, particularly in supportive care and symptom-management trials. Employ in routine clinical oncology to screen for and monitor fatigue in all patients, with particular attention during and immediately post-treatment. Ideal for rapid repeated assessment (e.g., weekly) to track acute fatigue changes and guide real-time supportive interventions. In survivorship, use periodic BFI assessment (baseline, 6 months, 12 months) to identify persistent fatigue and tailor long-term rehabilitation. Excellent for busy clinics because of minimal time burden and clarity of interpretation.
Strengths & limitations
- Ultra-brief design (9 items, ~2 min); feasible for high-volume oncology clinics and repeated administration without patient burden or fatigue from questionnaire completion itself.
- Clear severity–interference structure; enables rapid triage of clinically significant fatigue and guides targeted intervention (e.g., high severity/low interference = reassurance; high interference = urgent referral).
- Extensively validated across cancer types, languages, and treatment settings; robust psychometric properties (Cronbach α ≥0.85 for subscales); responsive to change with exercise, supportive care, and symptom-modifying treatments.
- 0–10 NRS format familiar to oncology patients; allows direct comparison with pain and other symptom assessments in the M.D. Anderson Symptom Inventory and other symptom-cluster research.
- Limited dimensionality; unlike Piper Fatigue Scale, BFI does not decompose fatigue into behavioral, affective, sensory, or cognitive components. Severity–interference structure is pragmatic but less mechanistic.
- No universal clinical cutoff for severity categories; 0–3, 4–6, 7–10 are empirical approximations. Clinically meaningful change estimates vary by population and baseline severity.
- Minimal ceiling effect in early-stage or well-managed populations, but baseline fatigue levels vary widely across cancer types and treatment phases; reference data are essential for proper interpretation.
- NRS format dependent on literacy and cognitive ability to differentiate 11-point scales; may require verbal administration or adapted response options for populations with cognitive impairment.
Frequently asked
What is the difference between severity and interference subscales?
Severity measures how tired the patient feels (phenomenological experience); interference measures the functional impact of that fatigue on daily life. A patient may have moderate severity (5/10) but high interference (9/10) if fatigue profoundly disrupts their activities, relationships, and mood. Conversely, high severity (8/10) with low interference (3/10) suggests the patient is coping well despite fatigue. Clinically, interference often drives intervention priority.
What is a clinically meaningful change in BFI scores?
Published estimates suggest changes of ≥1.5–2.0 points on the 0–10 scale represent clinically meaningful improvement, particularly in intervention trials. Smaller changes (≥1.0 point) may be clinically relevant in high-burden populations (e.g., severe baseline fatigue). Use baseline severity, effect-size benchmarks (Cohen d), and anchor-based minimal clinically important differences when available.
Can BFI be administered by telephone or electronically?
Yes. BFI is ideally suited for telephone symptom screening (e.g., weekly calls during active treatment) and electronic platforms (web, mobile apps, SMS). The 0–10 NRS format is familiar and easily conveyed verbally or digitally. Ensure consistent administration modality within a patient's serial assessments and account for modality effects (telephone vs. in-person) if comparing groups.
How does BFI compare to other fatigue scales?
BFI is rapid and practical (2–3 min); Piper Fatigue Scale is more detailed and multidimensional (5–10 min, four subscales); Chalder Fatigue Scale is dimensionless but slightly longer; Multidimensional Fatigue Inventory is comprehensive but lengthy (20 items). Choose BFI for screening and repeated clinical assessment; use Piper or MFI if detailed fatigue phenotyping is required for research.
Sources
- Mendoza, T. R., Wang, X. S., Cleeland, C. S., et al. (1999). The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer, 85(5), 1186–1196. DOI: 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N ↗
- Cleeland, C. S., Mendoza, T. R., Wang, X. S., et al. (2000). Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer, 89(7), 1634–1646. DOI: 10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v ↗
How to cite this page
ScholarGate. (2026, June 3). Brief Fatigue Inventory (BFI). ScholarGate. https://scholargate.app/en/oncology-nursing/brief-fatigue-inventory
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Cancer Fatigue ScaleOncology Nursing↔ compare
- ESASOncology Nursing↔ compare
- FACT-GOncology Nursing↔ compare
- MFIOncology Nursing↔ compare
- Piper Fatigue ScaleOncology Nursing↔ compare